BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31261173)

  • 1. The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.
    Flood VH; Garcia J; Haberichter SL
    Curr Opin Hematol; 2019 Sep; 26(5):331-335. PubMed ID: 31261173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
    Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
    J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of slightly reduced von Willebrand factor activity.
    Bykowska K; Ceglarek B
    Pol Arch Intern Med; 2020 Mar; 130(3):225-231. PubMed ID: 31990275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.
    van Loon JE; Sanders YV; de Wee EM; Kruip MJ; de Maat MP; Leebeek FW
    PLoS One; 2012; 7(7):e40624. PubMed ID: 22792389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of multiple genetic variations with plasma levels of Von Willebrand Factor and clinical phenotype in Iranian patients with Von Willebrand disease type 1.
    Zafarani A; Tabibian S; Barati M; Ghodratnia E; Safa M
    Transfus Apher Sci; 2023 Oct; 62(5):103766. PubMed ID: 37550093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis and treatment of Von Willebrand disease.
    Sharma R; Flood VH
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):379-384. PubMed ID: 29222282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.
    Casonato A; Cattini MG; Barbon G; Daidone V; Pontara E
    Thromb Res; 2015 Sep; 136(3):682-6. PubMed ID: 26251079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative impact of using different criteria for the laboratory diagnosis of type 1 von Willebrand disease.
    Quiroga T; Goycoolea M; Belmont S; Panes O; Aranda E; Zúñiga P; Pereira J; Mezzano D
    J Thromb Haemost; 2014 Aug; 12(8):1238-43. PubMed ID: 24796601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
    Flood VH; Friedman KD; Gill JC; Haberichter SL; Christopherson PA; Branchford BR; Hoffmann RG; Abshire TC; Dunn AL; Di Paola JA; Hoots WK; Brown DL; Leissinger C; Lusher JM; Ragni MV; Shapiro AD; Montgomery RR
    Blood; 2013 May; 121(18):3742-4. PubMed ID: 23520336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic basis of von Willebrand disease.
    Goodeve AC
    Blood Rev; 2010 May; 24(3):123-34. PubMed ID: 20409624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
    Flood VH; Christopherson PA; Gill JC; Friedman KD; Haberichter SL; Bellissimo DB; Udani RA; Dasgupta M; Hoffmann RG; Ragni MV; Shapiro AD; Lusher JM; Lentz SR; Abshire TC; Leissinger C; Hoots WK; Manco-Johnson MJ; Gruppo RA; Boggio LN; Montgomery KT; Goodeve AC; James PD; Lillicrap D; Peake IR; Montgomery RR
    Blood; 2016 May; 127(20):2481-8. PubMed ID: 26862110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.
    Atiq F; Blok R; van Kwawegen CB; Doherty D; Lavin M; van der Bom JG; O'Connell NM; de Meris J; Ryan K; Schols SEM; Byrne M; Heubel-Moenen FCJI; van Galen KPM; Preston RJS; Cnossen MH; Fijnvandraat K; Baker RI; Meijer K; James P; Di Paola J; Eikenboom J; Leebeek FWG; O'Donnell JS
    Blood; 2024 Apr; 143(14):1414-1424. PubMed ID: 38142407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic pitfalls and conundrums in type 1 von Willebrand disease.
    Sidonio RF; Lavin M
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):618-623. PubMed ID: 36485079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD.
    Roberts JC; Christopherson PA; Tarantino MD; Gonzales SE; Morateck PA; Perry CL; Flood VH; Abshire TC; Montgomery RR;
    Haemophilia; 2024 Jan; 30(1):161-168. PubMed ID: 38013388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
    Flood VH; Gill JC; Morateck PA; Christopherson PA; Friedman KD; Haberichter SL; Hoffmann RG; Montgomery RR
    Blood; 2011 Feb; 117(6):e67-74. PubMed ID: 21148813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test.
    Michiels JJ; Smejkal P; Penka M; Batorova A; Pricangova T; Budde U; Vangenechten I; Gadisseur A
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):518-531. PubMed ID: 27443694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the diagnosis and management of type 1 von Willebrand disease.
    Castaman G; Rodeghiero F
    Expert Rev Hematol; 2011 Feb; 4(1):95-106. PubMed ID: 21322782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.
    Kalot MA; Husainat N; El Alayli A; Abughanimeh O; Diab O; Tayiem S; Madoukh B; Dimassi AB; Qureini A; Ameer B; Eikenboom JCJ; Giraud N; McLintock C; McRae S; Montgomery RR; O'Donnell JS; Scappe N; Sidonio RF; Brignardello-Petersen R; Flood VH; Connell NT; James PD; Mustafa RA
    Blood Adv; 2022 Jan; 6(1):62-71. PubMed ID: 34610118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
    Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
    Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants of enhanced von Willebrand factor clearance from plasma.
    Seidizadeh O; Baronciani L; Pagliari MT; Cozzi G; Colpani P; Cairo A; Siboni SM; Biguzzi E; Peyvandi F
    J Thromb Haemost; 2023 May; 21(5):1112-1122. PubMed ID: 36754679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.